Clinical Cardiology Alert – April 1, 2003
April 1, 2003
View Issues
-
Treating In-Hospital Cardiac Arrest with an Automatic External Cardioverter Defibrillator
In this study, a European consortium of investigators evaluated the ability of an automatic external cardioverter defibrillator (AECD) to detect and treat arrhythmias in the in-hospital setting. -
Cardiac Resynchronization for Heart Failure
Cardiac resynchronization reduces the mortality of progressive heart failure in patients with symptomatic left ventricular dysfunction and dyssynchrony. -
Acetylcysteine for Prevention of Acute Renal Dysfunction after Coronary Angiography
While the clinical benefit of oral N-acetylcysteine on reducing rates of contrast nephropathy for a given patient is unproven, it should be considered for all patients with abnormal renal function referred for elective coronary angiography. -
Rheumatoid Arthritis: A New CAD Risk Factor
Rheumatoid arthritis should be recognized as a marker of increased risk for myocardial infarction. -
Fibrinolysis For Mechanical Prosthetic Valve Thrombosis
Although fibrinolytic therapy was highly successful for thrombosis of prosthetic mechanical heart valves, a high complication rate limits its use to nonsurgical candidates. -
Immunosuppressive Therapy for Myocarditis
In patients with active lymphocytic myocarditis and persistent heart failure for greater than 6 months, those with circulating cardiac autoantibodies and no viral genomes detected on myocardial biopsy are the most likely to benefit from immunosuppressive therapy. -
Pharmacology Watch: Warfarin Effectively Prevents Venous Thromboembolism
Low intensity warfarin therapy effectively prevents recurrent venous thromboembolism, according to a recent study in the New England Journal of Medicine. -
Clinical Briefs in Primary Care Supplement